Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-13736 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD137 Monoclonal Antibody (BBK-2), Biotin
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Description
- MA5-13736 targets CD137 in FACS and IF applications and shows reactivity with Human samples.
- Conjugate
- Biotin
- Antibody clone number
- BBK-2
- Concentration
- 0.2 mg/mL
Submitted references Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression.
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
CD137 enhances monocyte-ICAM-1 interactions in an E-selectin-dependent manner under flow conditions.
CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.
Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling.
Molecular mechanisms and gene regulation of melphalan- and hyperthermia-induced apoptosis in Ewing sarcoma cells.
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
Ho WT, Pang WL, Chong SM, Castella A, Al-Salam S, Tan TE, Moh MC, Koh LK, Gan SU, Cheng CK, Schwarz H
Cancer research 2013 Jan 15;73(2):652-61
Cancer research 2013 Jan 15;73(2):652-61
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
Anderson MW, Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, Houot R, Azambuja D, Biasoli I, Morais JC, Spector N, Molina-Kirsch HF, Warnke RA, Levy R, Natkunam Y
The American journal of pathology 2012 Sep;181(3):795-803
The American journal of pathology 2012 Sep;181(3):795-803
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, Lossos IS, Levy R
Blood 2011 Aug 4;118(5):1350-8
Blood 2011 Aug 4;118(5):1350-8
CD137 enhances monocyte-ICAM-1 interactions in an E-selectin-dependent manner under flow conditions.
Quek BZ, Lim YC, Lin JH, Tan TE, Chan J, Biswas A, Schwarz H
Molecular immunology 2010 May;47(9):1839-47
Molecular immunology 2010 May;47(9):1839-47
CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.
Baessler T, Charton JE, Schmiedel BJ, Grünebach F, Krusch M, Wacker A, Rammensee HG, Salih HR
Blood 2010 Apr 15;115(15):3058-69
Blood 2010 Apr 15;115(15):3058-69
Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling.
Jiang D, Yue PS, Drenkard D, Schwarz H
Stem cells (Dayton, Ohio) 2008 Sep;26(9):2372-81
Stem cells (Dayton, Ohio) 2008 Sep;26(9):2372-81
Molecular mechanisms and gene regulation of melphalan- and hyperthermia-induced apoptosis in Ewing sarcoma cells.
Krause C, Klüttermann K, Mauz-Körholz C
Anticancer research 2008 Sep-Oct;28(5A):2585-93
Anticancer research 2008 Sep-Oct;28(5A):2585-93
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA, Kiener PA
Journal of immunology (Baltimore, Md. : 1950) 2000 Sep 1;165(5):2903-10
Journal of immunology (Baltimore, Md. : 1950) 2000 Sep 1;165(5):2903-10
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA, Kiener PA
Journal of immunology (Baltimore, Md. : 1950) 2000 Sep 1;165(5):2903-10
Journal of immunology (Baltimore, Md. : 1950) 2000 Sep 1;165(5):2903-10
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry analysis of CD137 in PBMC cells stimulated with PHA for 3 days (green) compared to an isotype control (blue). Human blood was collected, combined with a hydrophilic polysaccharide, centrifuged, transferred to a conical tube and washed with PBS. 50 µL of cell solution was added to each tube at a dilution of 2x10^7 cells/mL, followed by the addition of 50 µL of isotype control and primary antibody (Product # MA5-13739) at a dilution of 1 µg/test. Cells were incubated for 30 min at 4ºC and washed with a cell buffer, followed by incubation with a DyLight 488-conjugated secondary antibody for 30 min at 4ºC in the dark. FACS analysis was performed using 400 µL of cell buffer.
- Conjugate
- Biotin